In this issue:
Impact of guideline-directed therapy on hospitalisation rates in patients with CKD
Impact of SBP on readmissions and mortality in patients hospitalised with AKI
ED utilisation by dialysis patients
Simple risk score for predicting severe cisplatin-associated AKI
Prescription of QT-prolonging medications in dialysis patients
Predicting the risk of kidney failure and death in adults with moderate to severe CKD
Clinical decision support for hypertension management in CKD
First-in-class atacicept for treatment of IgA nephropathy
Alternate-day prednisolone vs levamisole in frequently-relapsing nephrotic syndrome
Epidemiology and clinical outcomes of community-acquired AKI
Please login below to download this issue (PDF)